ATE292117T1 - Zusammensetzungen zur behandlung von hautkrankheiten - Google Patents
Zusammensetzungen zur behandlung von hautkrankheitenInfo
- Publication number
- ATE292117T1 ATE292117T1 AT00900030T AT00900030T ATE292117T1 AT E292117 T1 ATE292117 T1 AT E292117T1 AT 00900030 T AT00900030 T AT 00900030T AT 00900030 T AT00900030 T AT 00900030T AT E292117 T1 ATE292117 T1 AT E292117T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- skin diseases
- alkyl
- compositions
- formula
- Prior art date
Links
- 208000017520 skin disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 206010053615 Thermal burn Diseases 0.000 abstract 1
- 208000024963 hair loss Diseases 0.000 abstract 1
- 230000003676 hair loss Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL330768A PL190755B1 (pl) | 1999-01-07 | 1999-01-07 | Preparat do leczenia i profilaktyki chorób skóry |
| PCT/IB2000/000019 WO2000040559A1 (en) | 1999-01-07 | 2000-01-07 | Compositions for the treatment of skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE292117T1 true ATE292117T1 (de) | 2005-04-15 |
Family
ID=20073560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00900030T ATE292117T1 (de) | 1999-01-07 | 2000-01-07 | Zusammensetzungen zur behandlung von hautkrankheiten |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1147086B9 (de) |
| AT (1) | ATE292117T1 (de) |
| AU (1) | AU1792700A (de) |
| CZ (1) | CZ299662B6 (de) |
| DE (1) | DE60019086T2 (de) |
| ES (1) | ES2238985T3 (de) |
| HU (1) | HU225475B1 (de) |
| PL (2) | PL190755B1 (de) |
| RU (1) | RU2199319C1 (de) |
| SK (1) | SK285869B6 (de) |
| UA (1) | UA73491C2 (de) |
| WO (1) | WO2000040559A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
| SE0102380D0 (sv) * | 2001-07-02 | 2001-07-02 | Macronova Ab | Kräm för behandling av åldersförändringar i huden hos människa |
| RU2336867C2 (ru) * | 2003-05-30 | 2008-10-27 | ПАОЛИ АМБРОЗИ Джанфранко ДЕ | Композиция для дермального применения, обладающая фотозащитным и антиэритемным действием, содержащая солнечный фильтр и диметилсульфон |
| RU2266538C2 (ru) * | 2003-08-27 | 2005-12-20 | Ванчакова Нина Павловна | Способ идентификации противозудного эффекта антидепрессанта |
| PL364348A1 (en) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
| DE102004013798A1 (de) * | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material |
| PL1919466T3 (pl) | 2005-07-11 | 2012-05-31 | Cortria Corp | Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu |
| DE602006008349D1 (de) * | 2005-12-09 | 2009-09-17 | Cerecon Ag | Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel |
| CA2657606A1 (en) * | 2006-03-08 | 2007-09-13 | Cortria Corporation | Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries |
| WO2008062324A2 (en) * | 2006-10-11 | 2008-05-29 | Dermena | Compositions comprising nicotinamide and wakame extract having skin anti-aging properties |
| JP2010506900A (ja) * | 2006-10-18 | 2010-03-04 | デルメナ | リポ蛋白質異常症並びに皮膚疾病および皮膚障害の処置のためのｎ−メチルニコチンアミドを含有する食品抽出物 |
| RU2470645C2 (ru) * | 2007-09-10 | 2012-12-27 | Гленмарк Фармасьютикалс Лимитед | Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида |
| EP2211858B1 (de) | 2007-10-12 | 2015-03-25 | Politechnika Lodzka | Verwendung von quarternären pyridiniumsalzen zur inhibition von tumor metastasen |
| TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類 |
| WO2018015862A1 (en) | 2016-07-18 | 2018-01-25 | Pharmena S.A. | 1-methylnicotinamide salts for use in raising the blood levels of adiponectin |
| JP7608422B2 (ja) | 2019-07-12 | 2025-01-06 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | 生体エネルギー組み合わせ及びそれの使用方法 |
| WO2021205341A1 (en) | 2020-04-07 | 2021-10-14 | Pharmena S.A. | 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases |
| PL246761B1 (pl) * | 2023-05-10 | 2025-03-03 | Politechnika Poznanska | Sposób otrzymywania czwartorzędowych soli amoniowych z kationem 3-karbamoilo-1-alkilopirydyniowym i anionem salicylanowym |
| PL248942B1 (pl) * | 2024-01-31 | 2026-02-16 | Politechnika Poznanska | Czwartorzędowe sole amoniowe zawierające anion 2-furanokarboksylanowy i kation będący alkilową pochodną nikotynamidu, sposób ich otrzymywania i zastosowanie jako środki myjąco-dezynfekujące |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| US4067975A (en) * | 1975-08-04 | 1978-01-10 | Yu Ruey J | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide |
| US4505896A (en) * | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| US4578394A (en) * | 1984-12-10 | 1986-03-25 | Hoechst-Roussel Pharmaceuticals Incorporated | Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines |
| DE3603601C3 (de) * | 1986-02-06 | 1999-12-23 | Jutta Mai | Verwendung eines Bockshornkleesamenextraktes |
| US4786647A (en) * | 1986-06-30 | 1988-11-22 | University Of Florida | Method for eliciting anxiolysis |
| ZA892928B (en) * | 1988-04-25 | 1991-01-30 | Pro Neuron Inc | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| US5372911A (en) * | 1991-06-13 | 1994-12-13 | Dainippon Ink And Chemicals, Inc. | Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor |
| US6238678B1 (en) * | 1995-11-06 | 2001-05-29 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin B3 compound |
| RU2085187C1 (ru) * | 1995-11-22 | 1997-07-27 | Исследовательская корпорация МДТ | Гель для ухода за кожей и лечения ее заболеваний и композиция для его получения |
| US6028111A (en) * | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US20040102358A1 (en) * | 1997-05-19 | 2004-05-27 | Scivoletto Rosemarie | Composition for treating skin conditions |
| AU3082699A (en) * | 1998-03-16 | 1999-10-11 | Procter & Gamble Company, The | Method of treating skin irritation |
-
1999
- 1999-01-07 PL PL330768A patent/PL190755B1/pl unknown
-
2000
- 2000-01-07 CZ CZ20012450A patent/CZ299662B6/cs not_active IP Right Cessation
- 2000-01-07 AU AU17927/00A patent/AU1792700A/en not_active Abandoned
- 2000-01-07 DE DE60019086T patent/DE60019086T2/de not_active Expired - Lifetime
- 2000-01-07 SK SK951-2001A patent/SK285869B6/sk not_active IP Right Cessation
- 2000-01-07 HU HU0104963A patent/HU225475B1/hu unknown
- 2000-01-07 AT AT00900030T patent/ATE292117T1/de active
- 2000-01-07 EP EP00900030A patent/EP1147086B9/de not_active Expired - Lifetime
- 2000-01-07 ES ES00900030T patent/ES2238985T3/es not_active Expired - Lifetime
- 2000-01-07 WO PCT/IB2000/000019 patent/WO2000040559A1/en not_active Ceased
- 2000-01-07 RU RU2001121650/14A patent/RU2199319C1/ru active
- 2000-01-07 PL PL396696A patent/PL396696A1/pl unknown
- 2000-07-01 UA UA2001075379A patent/UA73491C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2001121650A (ru) | 2004-02-27 |
| SK9512001A3 (en) | 2001-12-03 |
| HUP0104963A2 (hu) | 2002-04-29 |
| PL190755B1 (pl) | 2006-01-31 |
| CZ20012450A3 (cs) | 2002-10-16 |
| UA73491C2 (uk) | 2005-08-15 |
| PL396696A1 (pl) | 2012-01-16 |
| EP1147086B1 (de) | 2005-03-30 |
| ES2238985T3 (es) | 2005-09-16 |
| WO2000040559A1 (en) | 2000-07-13 |
| DE60019086D1 (de) | 2005-05-04 |
| CZ299662B6 (cs) | 2008-10-08 |
| AU1792700A (en) | 2000-07-24 |
| HUP0104963A3 (en) | 2002-11-28 |
| DE60019086T2 (de) | 2006-02-02 |
| RU2199319C1 (ru) | 2003-02-27 |
| SK285869B6 (sk) | 2007-10-04 |
| ES2238985T9 (es) | 2011-03-24 |
| HU225475B1 (en) | 2006-12-28 |
| EP1147086A1 (de) | 2001-10-24 |
| EP1147086B9 (de) | 2010-09-22 |
| PL330768A1 (en) | 2000-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019086D1 (de) | Zusammensetzungen zur behandlung von hautkrankheiten | |
| SE9604786D0 (sv) | New compounds | |
| TR200102072T2 (tr) | İltihap karşıtı maddeler olarak aromatik çok döngülü bileşimler | |
| ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| DOP2000000114A (es) | Oxazolidinonas substituidas y su uso | |
| TR200001840T2 (tr) | Arile bağlı azopolisiklik bileşikler | |
| ATE119520T1 (de) | Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung. | |
| DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
| SE0100569D0 (sv) | New compounds | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
| ATE322878T1 (de) | Biotin enthaltende galenische formulierung | |
| DK284386D0 (da) | Farmaceutisk praeparat mod hudlidelser | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DE69530988D1 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| DE69819539D1 (de) | Antithrombotische mittel | |
| CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| DE60139409D1 (de) | Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen | |
| KR960010003A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| DE60119514D1 (de) | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure | |
| TR199900013T2 (xx) | Yeni bile�ikler. | |
| HRP20040421B1 (hr) | INHIBICIJA VIRUSA n-DOKOZANOLOM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1147086 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |